“…The described cellular and molecular components of the HSC niche ( 3 ) are continuously expanding, and today include both endosteal and endothelial components such as: mesenchymal stromal cells (MSCs), ( 4–6 ) arteriolar ( 7 ) and sinusoidal ( 8,9 ) endothelial cells (ECs), osteoblasts (OBs), ( 10–13 ) spindle‐shaped N‐cadherin + CD45 − osteoblastic cells (SNO cells), ( 12 ) macrophages, ( 14 ) megakaryocytes, ( 15 ) T cells, ( 16 ) the sympathetic nervous system (SNS) through β‐adrenergic signaling, ( 17,18 ) perivascular stromal cells ( 19 ) including LepR + skeletal stem cells, ( 20 ) chemokine (C‐X‐C motif) ligand 12 (CXCL12)‐abundant reticular (CAR) cells, ( 21 ) skeletal lineage cells, ( 22 ) Schwann cells, ( 23 ) and adipocytes. ( 24,25 ) These niche cells produce numerous regulatory factors that are vital for HSC quiescence and regeneration, and control of differentiation, including various cell‐surface proteins, extracellular cytokines, and inflammatory molecules, such as CXCL12, ( 5,21 ) angiopoietin‐1 (Ang‐1), ( 26 ) thrombopoietin (TPO), ( 27 ) stem cell factor (SCF), ( 28 ) C‐C motif chemokine ligand 3 (CCL3), ( 29,30 ) and angiogenin (ANG), ( 31 ) as well as variable oxygen tension and reactive oxygen species (ROS).…”